CEO and Co-Founder
Anne co-founded 23andMe in 2006 after a decade spent in healthcare investing, focused primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Presently, 23andMe has built one of the world’s largest databases of individual genetic information. Its novel, web-based research approach allows for the rapid recruitment of participants to many genome-wide association studies at once, reducing the time and money needed to make new discoveries, and the company has created a proven and standardized resource for finding new genetic association and confirming genetic loci discovered by others. Under Anne’s leadership 23andMe has made significant advances in bringing personalized medicine directly to the public. Anne graduated from Yale University with a BS in Biology. Getting access to and understanding her own genetic information had always been one of her ambitions.
Andy Page brings corporate leadership, financial acumen and deep operational expertise to 23andMe. Andy has been a member of the 23andMe board of directors since 2012 and joined the company as president in 2013. Andy leads the company’s product and engineering, marketing, finance, business development, laboratory operations and legal/regulatory affairs functions. In addition, he is responsible for developing the company’s business strategy and identifying opportunities for long-term growth and industry leadership. Before joining 23andMe, Andy served as the president of Gilt Groupe, an online luxury shopping destination, where he oversaw the Company’s various businesses and operations including Women’s, Men’s, Kids & Baby, Home, Park & Bond, Gilt City and Gilt Taste. He joined Gilt in April 2010 as the chief financial officer and transitioned to president in 2011. Prior to joining Gilt, Andy was chief operating and financial officer at PlayPhone, Inc., where he was responsible for managing the company’s multinational operations. Before PlayPhone, Andy was CFO and SVP of Business Strategy of StubHub Inc. There he managed the company’s financial operations, business strategy, financial reporting, and administrative functions. He led the company’s sale to eBay in 2007. Andy has also held senior executive positions at Panasas Inc., ONI Systems Corp., and Robertson Stephens & Company. Andy holds a B.A. from Princeton University and a MBA from Harvard Business School. He is an advisor to several private e-commerce companies. He also serves on the board of directors of My New Red Shoes, a nonprofit organization that provides back-to-school clothes for homeless and low-income children in the San Francisco Bay Area.
Brian T. Naughton, PhD
Brian joined 23andMe at its founding drawing on his experience in bioinformatics, statistics and genetics to analyze data, develop algorithms and translate scientific research to drive the world’s first Personal Genome Service®. Among other projects, Dr. Naughton has worked on the design of the 23andMe custom chip which now analyzes over 1 million SNPs and the development of tools related both to risk estimation and ancestry. Brian received his PhD from the Biomedical Informatics program at Stanford University and is a graduate of Trinity College, Dublin in Ireland.
Chris joined 23andMe in 2012 as Vice President, Communications, with responsibility for the company’s corporate communications, media relations and investor relations initiatives. Prior to joining 23andMe, Chris served as Senior Vice President, Corporate Relations, for Genentech, as well as Chief Communications Officer for Yahoo! Inc. and Vice President, Corporate Communications for The Walt Disney Company. Chris has a bachelor of arts degree in journalism and a master of arts degree in communications management, both from the University of Southern California.
Joanna L. Mountain, PhD
Senior Director of Research
Joanna joined 23andMe in 2007 as a senior member of the Research Team. She served on the faculties of the Anthropological Sciences and Genetics Departments at Stanford University. Dr. Mountain’s professional and research interests include the patterns of genetic etiology across a broad range of human traits, the prehistory underlying human genetic diversity, and the nature of the relationship between genetic diversity and categories of race and ethnicity. Joanna has been awarded multiple grants from the National Science Foundation and the National Institutes of Health and has published over 40 papers in the field of human genetics. She spent two years as a Peace Corps volunteer teaching at a community school near the Kenyan coast and continues to be particularly interested in the genetic diversity of Africa. Dr. Mountain earned a PhD in Genetics and a BS in Mathematical Sciences, both from Stanford, and conducted postdoctoral research on human evolutionary genetics at the University of California, Berkeley.
VP Strategic Alliances
Jonathan Ward joined 23andMe in 2012 serving as Vice President, Strategic Alliances, with responsibility for the company’s strategic partnerships. Prior to joining 23andMe, Jonathan served most recently as interim Chief Marketing Officer at eHarmony.com and held a variety of marketing and business development roles during his eight-year tenure there. Jonathan has also held marketing and business development roles at America Online, McKinsey & Company as well as Ogilvy, Adams & Rinehart. Jonathan has a bachelor of arts degree in English from Williams College and holds a masters in management from the J.L. Kellogg School of Management at Northwestern University.
Director of Regulatory Affairs and Quality Assurance
Judith joined 23andMe in 2011 and is responsible for regulatory affairs and quality assurance. Prior to joining 23andMe, she worked in a number of in vitro diagnostic companies, most recently at XDx as Director of Regulatory Affairs and Quality Assurance. She also worked at Novartis Diagnostics, Cepheid and several small and successful start-up companies leading marketing, regulatory affairs, quality assurance and clinical affairs efforts. Judith received an MS in Clinical Science from San Francisco State University and a BS in Microbiology from Cal Poly. She is certified by the American Society of Clinical Pathology as a Medical Laboratory Scientist.
As VP Marketing, Neil Rothstein is responsible for the marketing, branding and customer acquisition activities of the company. Prior to joining 23andMe, Neil worked at Netflix for 11 years most recently serving as VP, Online Marketing where he led the company’s global online marketing activities across the US, Canada, Latin America, UK, and Ireland. Neil has also had roles with RateItAll, ESPN, and the Atlanta Committee for the Olympic Games. Neil received an MBA from the Gouizueta Business School at Emory University and a BA in Economics from Brandeis University.
VP Product and Engineering
Steve joined 23andMe in 2010 and is responsible for product and engineering. Prior to 23andMe, Steve was VP of engineering at Loopt and co-founder and VP of technology at Glimpse.com (acquired by TheFind.com). Earlier Steve served as the VP of engineering for Consumer Products and Solutions at Symantec and headed the engineering team at Cendura (acquired by CA), growing development and QA teams in both the U.S. and India. He also served as the SVP and GM of the Internet Portal Division for Healtheon/WebMD (IPO: HLTH), where he operated worldwide engineering and business teams and drove M&A technology integration. He holds three U.S. patents in the area of Object Oriented Operating System Technology. Steve received a BS in Computer Science from Ohio State University.
Uta Francke, MD
Senior Medical Director
Uta was appointed Senior Medical Director at 23andMe in 2010, after serving as an Editorial Advisor. She is also professor emeritus on recall of Genetics and Pediatrics at Stanford University where she teaches medical and molecular genetics and teaches clinical genetics. Dr. Francke’s past research has ranged from human and mouse chromosome identification and gene mapping to the discovery of genes involved in heritable disorders, studies of their functions and of disease-causing mechanisms. Applying genomic technologies to mammalian genetics research, her most recent focus has been on the development of mouse models for human microdeletion syndromes. She is board-certified by the American Board of Pediatrics and the American Board of Medical Genetics in Clinical and Molecular Genetics and Cytogenetics. She has been an Investigator of the Howard Hughes Medical Institute and the recipient of the Antoine Marfan Award from the National Marfan Foundation and the Colonel Harland Sanders Lifetime Achievement Award in Genetics from the March of Dimes Birth Defects Foundation. She is a member of the Institute of Medicine of the National Academies and a fellow of the American Association for Advancement of Science and of the American Academy of Arts and Sciences. She is a past president of the American Society for Human Genetics and of the International Federation of Human Genetics Societies and a founding member of the American College of Medical Genetics. Dr. Francke holds an MD from the University of Munich, Germany.
Jeffrey D. Pollard, MD
Director of Medical Affairs
Dr. Pollard joined 23andMe as Director of Medical Affairs in 2012 and is responsible for the company’s efforts to advance the integration of personal genomics into the modern healthcare environment through educational initiatives and strategic partnerships with integral members of the healthcare system. He is a double board-certified physician and surgeon with over a decade of clinical experience and has published numerous research articles, contributed to textbooks and trained other surgeons around the nation. Prior to joining 23andMe, Dr. Pollard co-founded and served as Medical Director of Surgical Services for Réviance, a multi-center specialty practice and surgical center. He also served as Medical Expert Network Director for HealthTap, an innovative digital and mobile health platform. Dr. Pollard was also selected as a regional educator by Allergan, Inc. responsible for training healthcare providers in advanced medication delivery techniques to enhance clinical outcomes. Dr. Pollard holds a B.S. in Health Psychology from Duke University and M.D. from Vanderbilt University. He completed both his Internship in General Surgery and Residency in Otolaryngology-Head and Neck Surgery at Stanford University and fellowship training in Facial Plastic and Reconstructive Surgery with Calvin M. Johnson, Jr., M.D. at Tulane University. He is a member of the American Academy of Facial Plastic & Reconstructive Surgery and the American Academy of Otolaryngology-Head and Neck Surgery.